Travelers EVP Lefebvre sells $6.01m in company stock By Investing.com

Mojgan M. Lefebvre, Executive Vice President and Chief Technology & Operations Officer at The Travelers Companies, Inc. (), disposed of company shares totaling approximately $6.01 million on July 21, 2026. These transactions involved the sale of shares that were acquired through the exercise of stock options.

Ms. Lefebvre sold a total of 16,313 shares of Travelers common stock. The sales occurred at prices ranging between $368.3547 and $368.405 per share. One block of 9,213 shares was sold at a weighted average price of $368.3547, with individual prices for this block ranging from $368.16 to $368.57. Another block of 7,100 shares was sold at $368.405 per share. The total value received from these sales was $6,009,327.

Concurrently, Ms. Lefebvre acquired the same number of shares, 16,313, through the exercise of stock options. These acquisitions were made at prices ranging from $132.58 to $139.83 per share, totaling $2,214,252. Specifically, 9,213 shares were acquired at an exercise price of $132.58, and 7,100 shares were acquired at $139.83. Following these transactions, Ms. Lefebvre holds 21,214 derivative securities in the form of stock options.

For deeper insights into Travelers’ valuation and performance metrics, InvestingPro offers access to 15 additional ProTips and comprehensive financial analysis for this insurance industry leader.

In other recent news, Travelers Companies Inc. has reported strong second-quarter earnings, prompting several financial firms to adjust their price targets and ratings. Keefe, Bruyette & Woods raised its price target for Travelers to $373, acknowledging the company’s earnings beat and adjusting its 2026 and 2027 earnings estimates to $35.00 and $32.30 per share, respectively. Truist Securities also increased its price target to $425, citing momentum in earnings and revising its full-year 2026 earnings per share estimate to $34.10. Meanwhile, Goldman Sachs downgraded Travelers to a Sell rating, setting a price target of $350, due to concerns over valuation despite the positive earnings report. Raymond James, maintaining a Strong Buy rating, raised its price target to $430, highlighting a strong profitability outlook and sustained returns on equity. BofA Securities increased its price target to $307, noting a significant earnings beat with favorable reserve development contributing $1.90 per share. These developments reflect the varied perspectives of financial analysts on Travelers’ future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.